Patent Situation of HIV/AIDS-related Drugs in 80 Countries
(2000; 11 pages) Voir le document au format PDF
Table des matières
Afficher le documentAcknowledgements
Afficher le documentIntroduction
Afficher le documentWhat are patents and how are they regulated internationally?
Afficher le documentReview of patent expiry dates of HIV/AIDS drugs
Afficher le documentFurther readings
 

Acknowledgements

The authors are very grateful to Dr J.D. Quick (WHO/EDM), Dr M. Scholtz (WHO/HTP) and G. Velásquez (WHO/EDM) for their constructive comments. Professor C.M. Correa (University of Buenos Aires), Mr A. Otten (WTO), Mr R. Wilder (WIPO) and Ms S. Zarilli (UNCTAD) are also acknowledged for their technical review and contributions to the document.

Data provided in this document originate mainly from public databases. UNAIDS and WHO cannot be liable for the use of these data. Suggestions and updates are welcome and should be sent to medmail@who.int

The views expressed in this document by named authors are solely the responsibility of those authors.

This document is not a formal publication of either UNAIDS or WHO, and all rights are reserved by the organizations. The document may, however, be freely reviewed, abstracted, reproduced and translated, in part or in whole, but not for sale nor for use in conjunction with commercial purposes.

 

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 3 mai 2013